A Variant in XPNPEP2 Is Associated with Angioedema Induced by Angiotensin I–Converting Enzyme Inhibitors
The American Journal of Human Genetics2005Vol. 77(4), pp. 617–626
Citations Over TimeTop 10% of 2005 papers
Qing Duan, Borzoo Nikpoor, Marie‐Pierre Dubé, Giuseppe A. Molinaro, Inge A. Meijer, Patrick A. Dion, Daniel Rochefort, Judith Saint‐Onge, Leah Flury, Nancy J. Brown, James V. Gainer, Jean L. Rouleau, A Agostoni, Massimo Cugno, Pierre Simon, P. Clavel, J. Potier, Bassem Wehbe, Seddik Benarbia, J Marc-Aurèle, J Chanard, Tatiana Foroud, Albert Adam, Guy A. Rouleau
Related Papers
- → Cough and angioedema from angiotensin-converting enzyme inhibitors: new insights into mechanisms and management(2004)78 cited
- → The Importance of Complement Testing in Acquired Angioedema Related to Angiotensin-Converting Enzyme Inhibitors(2020)22 cited
- → The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers(2008)26 cited
- → Angiotensin-converting-enzyme inhibitor–induced angioedema(2021)7 cited
- Angioedema due to angiotensin-converting enzyme inhibition: an association frequently unrecognized.(1997)